Randox Molecular - Cardiac Risk Prediction Array

1,905 views

|

December 10, 2014

  • Share
  • An overview of the Randox Cardiac Risk Prediction Array, a molecular assay utilising innovative biochip array technology (BAT) to simultaneously genotype 19 SNPs associated with coronary heart disease for comprehensive genetic risk assessment, including a dedicated SNP to predict response to statin treatment, for reliable patient genotyping within one day.

    DiagnosticsGenomicsMicrofluidicsProteomics and Metabolomics

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.